Department of Neurosurgery, Beijing Tiantan Hospital affiliated to Capital Medical University.
Beijing Neurosurgical Institute.
J Craniofac Surg. 2022;33(2):e118-e122. doi: 10.1097/SCS.0000000000008049.
The aim of this study was to investigate the effectiveness, safety, complications, and prognosis of endoscopic endonasal surgery for pituitary adenomas with cavernous sinus invasion (CSI).
The clinical data of 803 pituitary adenomas with CSI surgeries performed in our single ward between January 1, 2006 and December 31, 2018 were retrospectively reviewed. The resection degree, bone invasion, endocrine examination, complications, and outcome were retrospectively summarized.
Gross total resection was achieved in 394 patients (49.1%) subtotal resection in 171 patients (21.3%) and partial resection in 238 patients (29.6%). Clinically variable analyses showed that there was a significant correlation between CSI and female, older age, operation history, and non-gross total resection (NGTR). Among the pituitary adenomas with CSI, there was a significant correlation between bone invasive and NGTR, Knosp classification, recurrence. K-M curves showed that young age, larger tumors, bilateral invasion, Grade 4 of Knosp classification, NGTR, and bone invasion were associated with pituitary adenomas regrowth. Multivariate analysis revealed that bone invasion, NGTR, and Grade 4 of Knosp classification were independent risk factors for pituitary adenomas regrowth. There was a significant correlation between CSI and female, older age, operation history, and tumor resection degree.
There was a significant correlation between CSI and female, older age, operation history, and tumor resection degree. The patients with CSI and bone invasion were likely to recurrent. Non-gross total resection, bone invasion, and Grade 4 of Knosp classification were independent risk factors for pituitary adenomas regrowth. Endoscopic endonasal surgery is an excellent choice for pituitary adenomas with CSI.
本研究旨在探讨内镜经鼻蝶窦入路治疗伴有海绵窦侵袭(CSI)的垂体腺瘤的疗效、安全性、并发症和预后。
回顾性分析 2006 年 1 月 1 日至 2018 年 12 月 31 日期间在我单一病房接受手术治疗的 803 例伴有 CSI 的垂体腺瘤患者的临床资料。回顾性总结肿瘤切除程度、骨质侵犯、内分泌检查、并发症及转归。
全切除 394 例(49.1%),次全切除 171 例(21.3%),部分切除 238 例(29.6%)。临床变量分析显示,CSI 与女性、年龄较大、有手术史和非全切除(NGTR)显著相关。在伴有 CSI 的垂体腺瘤中,骨质侵犯与 NGTR、Knosp 分级、复发显著相关。K-M 曲线显示,年龄较小、肿瘤较大、双侧侵袭、Knosp 分级 4 级、NGTR 和骨质侵犯与垂体腺瘤复发有关。多因素分析显示,骨质侵犯、NGTR 和 Knosp 分级 4 级是垂体腺瘤复发的独立危险因素。CSI 与女性、年龄较大、有手术史和肿瘤切除程度显著相关。
CSI 与女性、年龄较大、有手术史和肿瘤切除程度显著相关。伴有 CSI 和骨质侵犯的患者更易复发。非全切除、骨质侵犯和 Knosp 分级 4 级是垂体腺瘤复发的独立危险因素。内镜经鼻蝶窦入路是治疗伴有 CSI 的垂体腺瘤的一种较好选择。